Worldwide Clinical Trials brings deep scientific, operational, regulatory, and medical expertise across a diverse range of therapeutic areas. Our dedicated experts and specialized knowledge in key therapeutic areas ensure your studies are conducted with the highest standards of quality around the globe.



We’re committed to the clinical development of therapeutics across all cardiovascular and metabolic (CVM) conditions, including MASH/MASLD, obesity, diabetes and related metabolic disorders, congestive heart failure (CHF), pulmonary arterial hypertension (PAH), metabolic syndrome, lipid disorders, and other acute and chronic liver diseases. Let’s talk about your CVM trial.

Specializing in autoimmune, hematological, and kidney conditions and respiratory disorders, our IMID team brings tailored expertise to each study. From initial trial design to market entry, our experts are with you every step of the way.

With experience spanning indications across solid and hematologic malignancies, diverse treatment modalities, and complex programs, our team is resource-dedicated to oncology clinical development. Accelerate your oncology study with us.

Founded in neuroscience clinical development, we excel across a broad spectrum of conditions, including Alzheimer’s disease and dementia, neurodegenerative and movement disorders, pain management, psychiatry, and psychedelics. Explore how we can support your neuroscience study.

Through partnerships with advocacy organizations and communities around the world, our rare disease experts utilize their proven methodology to bring treatments to the patients and families waiting. Meet our experienced rare disease team.

Our Cell & Gene Therapy Hub is at the forefront of this evolving area of research. With highly experienced strategic and scientific leads, our expertise encompasses all modalities from in vivo gene editing regulatory strategy to gene-modified cell therapy operational complexities, and all nuances in between. Find out how we approach the complex intricacies of cell and gene therapy studies.